FDA approves Phase II clinical trial of stem cells for Lou Gehrig #39;s disease (ALS)
Dr. Eva Feldman, U-M neurologist and director of the A. Alfred Taubman Medical Research Institute, discusses the recent FDA approval of a new phase for a cli...
By:
UMHealthSystemMore here:
FDA approves Phase II clinical trial of stem cells for Lou Gehrig's disease (ALS) - Video